However, the use of QR-KLU significantly reduced the expression of CD31 and VEGF in the hypoxic tumor tissue, which suggested that QR-KLU could significantly inhibit tumor neovascularization and reduce the MVD in the tumor shown in Fig. 6. Here, VEGFA is linked to neoplasm.